The Street’s Key Stock Analysts Research Reports
$ESPR, $FLR, $JD, $LGND, $NVDA, $RTRX, $VNOM
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new tradingand investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Monday, as follows:
Esperion Therapeutics Inc. (NASDAQ:ESPR) analysts raised to Buy from Neutral at Citigroup. The 52-wk trading range is 33.06 – 82.68, and the consensus price target is 72.23. The stock ended trading on Friday at 48.12.
Fluor Corp. (NYSE:FLR) analysts raised to Buy from Hold at Canaccord Genuity. The 52-wk trading range is 37.04 – 62.09. The consensus price target is 58.57, and the stock ended trading Friday at 56.84
JD.com Inc. (NASDAQ:JD) saw its target price reduced at Stifel to 48 from 50. That compares with a consensus target of 46.01. Management at the company noted that sales growth slowed in July due to seasonality and a difficult prior-year comparison.
Ligand Pharmaceutical Inc. (NASDAQ:LGND) analysts started with a Neutral rating at Goldman Sachs with a 256 price target. The consensus target price is 251.35, and the stock closed Friday at 247.98, +8.32% on the day.
Nvidia Corp. (NASDAQ:NVDA) was raised to Outperform from Perform at Oppenheimer. The 52-wk trading range for the chip maker is 157.37 – 269.20, and the consensus price target is set at 295.67. The company posted solid earnings but indicated some weakness for the next quarter due to crypto loss.
Retrophin Inc. (NASDAQ:RTRX) analysts started with a Buy rating and a 36 price target at Canaccord Genuity. The consensus price target is 38.67. The stock ended trading on Friday at 28.50.
Viper Energy Partners L.P. (NASDAQ:VNOM) was raised to Buy from Hold and the price target was boosted to 42 from 38 at Stifel. That compares with a consensus target of 40.8. The stock closed Friday at 38.37.
Have a terrific week.
Latest posts by Paul Ebeling (see all)
- Ferrari (NYSE:RACE) Stock Continues to Mark All Time Highs - June 18, 2019
- President Trump Vs Fed, Gold Wins - June 18, 2019
- Olive Oil: 1 of the Best anti-Inflammatory Foods - June 18, 2019